SANDRA BREMNER-DEXTER: Open Payments
NPI 1386709012 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 15 payments from 10 companies in 2025. Trend: 2023 $1,486 · 2024 $1,115 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| Janssen Pharmaceuticals, Inc | 2 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Alkermes, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: REXULTI, AUSTEDO XR, SPRAVATO, INGREZZA, CAPLYTA, INVEGA SUSTENNA, LYBALVI, UZEDY.
Industry payments across WA — which companies pay providers there.
